Corporate Profile: Cannabis Life Sciences is the developer of a proprietary patent-pending extraction and conversion methodology  that has potential to increase both yield and quality of cannabinoid oils extracted from cannabis plants. At CLS Holdings, we have developed a “seed to sale” acquisition strategy that involves acquiring cannabis dispensaries, cultivators and producers. We’re beginning with the booming Nevada market, one of the fastest growing markets in the U.S., and plan to expand into other western states as a licensee/producer and retailer. CLS stands for “Cannabis Life Sciences,” in recognition of our patent-pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS Holdings has recently received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology. CLS has executed a definitive agreement to acquire the Oasis Cannabis companies (Alternative Solutions, LLC). The closing of the transaction is subject to the satisfaction of a number of conditions including our ability to raise cash, and as a result, there can be no assurance that we will be able to close the Oasis Acquisition. See CLS Holdings USA’s filings with the SEC for additional details.